- Home
- SUUN vs CHRS Comparison
SUUN vs CHRS Comparison
Compare SUUN & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUUN
- CHRS
- Stock Information
- Founded
- SUUN 2013
- CHRS 2010
- Country
- SUUN Canada
- CHRS United States
- Employees
- SUUN N/A
- CHRS N/A
- Industry
- SUUN
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SUUN
- CHRS Health Care
- Exchange
- SUUN Nasdaq
- CHRS Nasdaq
- Market Cap
- SUUN 141.2M
- CHRS 122.9M
- IPO Year
- SUUN N/A
- CHRS 2014
- Fundamental
- Price
- SUUN $2.15
- CHRS $1.11
- Analyst Decision
- SUUN Strong Buy
- CHRS Strong Buy
- Analyst Count
- SUUN 1
- CHRS 4
- Target Price
- SUUN $6.00
- CHRS $5.38
- AVG Volume (30 Days)
- SUUN 172.6K
- CHRS 1.9M
- Earning Date
- SUUN 05-14-2025
- CHRS 05-08-2025
- Dividend Yield
- SUUN N/A
- CHRS N/A
- EPS Growth
- SUUN N/A
- CHRS N/A
- EPS
- SUUN N/A
- CHRS 0.25
- Revenue
- SUUN $36,247,013.00
- CHRS $266,959,999.00
- Revenue This Year
- SUUN $32.05
- CHRS N/A
- Revenue Next Year
- SUUN $72.25
- CHRS $9.02
- P/E Ratio
- SUUN N/A
- CHRS $4.48
- Revenue Growth
- SUUN 43.76
- CHRS 3.78
- 52 Week Low
- SUUN $1.95
- CHRS $0.66
- 52 Week High
- SUUN $6.87
- CHRS $2.43
- Technical
- Relative Strength Index (RSI)
- SUUN 32.42
- CHRS 60.13
- Support Level
- SUUN $2.07
- CHRS $0.72
- Resistance Level
- SUUN $2.49
- CHRS $1.14
- Average True Range (ATR)
- SUUN 0.20
- CHRS 0.10
- MACD
- SUUN 0.02
- CHRS 0.04
- Stochastic Oscillator
- SUUN 17.53
- CHRS 88.53
About SUUN SolarBank Corporation Common Stock
SolarBank Corp is an independent renewable and clean energy project developer and asset operator based in Canada and the United States. It is engaged in the development and operation of solar photovoltaic power generation projects in the province of Ontario and the state of New York. The company operates in two principal geographical areas - Canada and United States with a substantial portion of its overall revenue being generated from United States.
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.